2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
12
Leukemia
12
Breast Neoplasms
11
Leukemia, Myeloid, Acute
9
Congenital Abnormalities
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
7
Multiple Myeloma
7
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Waldenstrom Macroglobulinemia
5
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Chronic-Phase
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Burkitt Lymphoma
5
Squamous Cell Carcinoma of Head and Neck
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma
4
Lung Neoplasms
4
Leukemia, Myeloid, Accelerated Phase
4
Head and Neck Neoplasms
4
Central Nervous System Neoplasms
4
Blast Crisis
4
Sezary Syndrome
3
Interventions
Sorafenib
68
Bevacizumab
44
Oxaliplatin
25
Doxorubicin
22
Gemcitabine
21
Fluorouracil
21
Radiosurgery
20
Nivolumab
19
durvalumab
18
Radiofrequency Ablation
18
pembrolizumab
17
lenvatinib
17
Cisplatin
17
Capecitabine
17
atezolizumab
14
Leucovorin
14
Hepatectomy
14
Radiotherapy
12
tremelimumab
10
Irinotecan
10
Drug Therapy
10
Cyclophosphamide
10
Carboplatin
10
Blood Specimen Collection
10
Ipilimumab
9
regorafenib
8
Liver Transplantation
8
Everolimus
8
Cryosurgery
8
Chemotherapy, Adjuvant
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
In Situ Hybridization, Fluorescence
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled